MNTA Insider Trading Activity and SEC Form 4 Filings
MNTA insider trading summary
No open-market insider purchases or sales of Momenta Pharmaceuticals Inc (MNTA) have been reported on SEC Form 4 in the past 12 months.
Latest MNTA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 20, 2020 | Ian Fier | Chief Mfg and Program Officer | Sell | $20K (383 @ $52.17) |
| Aug 20, 2020 | Ian Fier | Chief Mfg and Program Officer | Sell | $74K (1,425 @ $52.17) |
| Aug 19, 2020 | Jose-Carlos Gutierrez-Ramos | Director | Sell | $521K (10,000 @ $52.09) |
| Aug 13, 2020 | Anthony M. Manning | Chief Scientific Officer | Sell | $11K (363 @ $29.31) |
| Aug 13, 2020 | Anthony M. Manning | Chief Scientific Officer | Sell | $1K (40 @ $29.34) |
| Aug 13, 2020 | Craig A Wheeler | President & CEO | Sell | $79K (2,777 @ $28.55) |
| Aug 12, 2020 | Jo Ann Beltramello | Chief HR and Inf. Officer | Sell | $19K (673 @ $27.88) |
| Aug 11, 2020 | Jo Ann Beltramello | Chief HR and Inf. Officer | Sell | $175K (6,250 @ $28.03) |
| Aug 10, 2020 | Craig A Wheeler | President & CEO | Sell | $81K (2,601 @ $31.21) |
| Aug 10, 2020 | Ian Fier | Chief Mfg and Program Officer | Sell | $11K (330 @ $32.36) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.